SG Americas Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-39,000
Closed -$8K 3005
2021
Q4
$8K Buy
+39,000
New +$1.91M ﹤0.01% 3283
2020
Q1
Sell
-92,000
Closed -$43K 3449
2019
Q4
$43K Hold
92,000
﹤0.01% 3085
2019
Q3
$249K Hold
92,000
﹤0.01% 2249
2019
Q2
$309K Hold
92,000
﹤0.01% 2176
2019
Q1
$318K Hold
92,000
﹤0.01% 2219
2018
Q4
$609K Buy
+92,000
New +$4.8M 0.01% 1719
2018
Q1
Sell
-205,200
Closed -$1.02M 3273
2017
Q4
$1.02M Buy
205,200
+38,300
+23% +$2.37M 0.01% 1360
2017
Q3
$672K Buy
166,900
+59,200
+55% +$4.18M 0.01% 1574
2017
Q2
$153K Buy
+107,700
New +$8.13M ﹤0.01% 2612
2016
Q4
Sell
-51,000
Closed -$23K 3136
2016
Q3
$23K Buy
+51,000
New +$4.12M ﹤0.01% 3242
2014
Q1
Sell
-219,900
Closed -$13K 2450
2013
Q4
$13K Hold
219,900
﹤0.01% 2537
2013
Q3
$31K Hold
219,900
﹤0.01% 2854
2013
Q2
$214K Buy
+219,900
New +$10M ﹤0.01% 1704

Other funds holding CAH

SG Americas Securities's CAH Position: Q2 2026 in Review

SG Americas Securities reduced its Cardinal Health (CAH) stake by 58% in Q2 2026, selling an estimated $137M and leaving 487,269 shares worth $116M. The position accounts for 0.06% of the portfolio, ranked #196.

SG Americas Securities first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $242M in Q1 2026. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • SG Americas Securities held 487,269 shares of Cardinal Health worth $116M as of Q2 2026.
  • SG Americas Securities sold 660,137 Cardinal Health shares in Q2 2026, an estimated $137M.
  • Cardinal Health made up 0.06% of SG Americas Securities's portfolio in Q2 2026, its #196 holding.
  • SG Americas Securities first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • SG Americas Securities's Cardinal Health position peaked at $242M in Q1 2026.
  • 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.